- Two Cases of Combined Pregnancy Following IVF-ET.
-
Kyung Ah Lee, Yang Soo Kwak, Kuk Sun Han, Min Whan Koh, Tae Hyung Lee
-
Yeungnam Univ J Med. 1997;14(1):262-268. Published online June 30, 1997
-
DOI: https://doi.org/10.12701/yujm.1997.14.1.262
-
-
 Abstract
 PDF
- Combined intrauterine and ectopic (heterotopic) pregnancy occurs in approximately 1 in 30,000 spontaneous gestations. Heterotopic gestations are increased in women who have had reconstructive pelvic surgery, Pelvic inflammatory disease and artificial ovarian hyperstimulation. Patients who require assisted reproductive technologies, such as in vitro fertilization / embryo transfer and gamete intrafallopian transfer, also have an increased risk of a heterotopic pregnancy. We experienced two cases of combined pregnancy following IVF-ET. Following is a report of these cases with a brief review of references.
- Measurements of Mid-arm Circumference(MAC) and Mid-arm Circumference/Head Circumference(MAC/HC) Ratio as Indices of Nutritional Status in Newborn Infants.
-
Jae Jun Lee, Kyung Ah Lee, Young Hwan Lee, Son Moon Shin
-
Yeungnam Univ J Med. 1994;11(1):160-166. Published online June 30, 1994
-
DOI: https://doi.org/10.12701/yujm.1994.11.1.160
-
-
Abstract
PDF
- Mid-arm circumference and mid-arm circumference/head circumference ratio(MAC/HC) were measured in 207 AGA(appropriate for gestational age) infants delivered at 26 to 42 weeks of gestation from January 1990 to December 1993 in Yeungnam University Hospital, Taegu, Korea. There were linear relationships between MACs and MAC/HC ratios and gestational age(MAC : y=03181x -2.2069, r=0.81, p<0.001 ; MAC/HC ratio : y=0.049x+0.1128, r=0.62, ; < 0.001). Using standard curves of MAC and MAC/HC ratio according to the gestational age, measurement of MAC or MAC/HC ratio can be a noninvasive, simple method to evaluate the intrauterine growth of newborn infants and the nutritional status of growing premature infants.
- Effect of Recombinant Human Erythropoietin in the Anemia of Prematurity : a Pilot Study.
-
Kyung Ah Lee, Son Moon Shin, Yong Hoon Park, Jeong Ok Hah
-
Yeungnam Univ J Med. 1994;11(1):115-126. Published online June 30, 1994
-
DOI: https://doi.org/10.12701/yujm.1994.11.1.115
-
-
Abstract
PDF
- The recent availability of recombinant human erythropoietin has opened new perspectives in the management of a variety of anemias. Clinical trials have been initiated in several countries using different approaches and methodology. We randomly assigned twelve premature infants(gestational age < 32 week) at high risk of requiring erythrocyte transfusion for anemia of prematurity with either subcutaneous recombinant human erythropoietin or a placebo. Treatment with rHuEPO was initiated at a dose of 100 units/kg day for 3 days a week. All patients were given supplemental oral iron therapy at a dose of 3 mg/kg per day, as tolerated and oral vitamin E at a dose of 25 units per day. Treated and control babies did not differ with respect to weight, hematocrit, overall mean reticulocyte count or rate of growth respectively. However, reticulocyte counts increased earlier in patients given rHuEPO. We conclude that rHuEPO administration is safe and feasible at the dose studied.
|
E-Submission
Yeungnam University College of Medicine
